Stoltz Of Coudersport

CIMINO AUTO PARTS

Solomon's Auction & Yard Sale Page

Do You Know: You can buy this marquee ad on Solomon's words for the wise for your business or event for only $10. per day! It's just one of the low cost advertising options available. Your ad is viewed 30,000 to 50,000 times every day. Email us for information on other ad locations.

Monday, October 17, 2016

Continuing the Fight Against Breast Cancer

By Rep. Matt Baker (R-Tioga/Bradford/Potter)
This past year, I was humbled and honored to receive the Pennsylvania Breast Cancer Coalition Pink Ribbon Award, its highest award, and dedicate it to my sister-in-law fighting a rare form of inflammatory breast cancer.

Every woman who conquers breast cancer has an amazing story to share of their journey. The one common thread in every story is that early detection saves lives. October is Breast Cancer Awareness Month, and it’s hard to forget with pink ribbons, ties and professional athletes wearing pink.

The statistics bear repeating. One in eight women in the United States will be diagnosed with breast cancer in her lifetime. Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among women. Each year, more than 246,660 women and 40,000 men will be diagnosed with breast cancer in the nation.

One statistic that is trending in a positive direction is the number of people – 2.8 million – who are breast cancer survivors. They are living full lives after having been diagnosed.

Pennsylvania is making strides in the continued effort to support those who have been diagnosed with breast cancer. The Brest Density Notification Act requires mammography providers to notify women categorized as having dense breast tissue about their condition. Knowledge is power and this law has improved detection and prevention by educating patients about dense breast tissue and how it could conceal possible abnormalities during mammographic procedures.

Three-dimensional mammograms were approved by the Food and Drug Administration five years ago. In 2014, the American College of Radiology declared tomosynthesis, the medical term for three-dimensional mammography, to no longer be a mere investigational tool. Pennsylvania followed up last year by becoming the first state to require insurers to cover all screening mammograms, including the 3-D versions, at no out-of-pocket cost to consumers. To see a list of the mammography facilities that offer 3-D mammograms in Pennsylvania, please visit the Pennsylvania Breast Cancer Coalition’s website at pabreastcancer.org.

In July Pennsylvania became the 42nd state to provide patients equal access to anti-cancer treatments with the enactment of oral chemotherapy legislation (Act 73 of 2016). I was proud to author the enabling Oral Chemo Parity Legislation (House Bill 60).

Chemotherapy can have a violent effect on the human body as it does its job. Oral chemotherapy drugs are often as strong as those administered intravenously and may have fewer side effects. In some instances, oral medications are the only form of chemotherapy a patient can handle.

There is also the financial impact. Prior to Act 73, orally administered chemotherapy was covered under a health plan’s pharmacy benefit, which required patients to pay a percentage of the total cost of the drug (generally between 25-30 percent). This created an enormous financial barrier for patients to access these drugs prescribed by their cancer physician for treatment. Act 73 prohibits insurance policies from placing oral anti-cancer medications on a specialty tier or charging a copay for the medication.

Hopefully, these measures will help in saving lives and make treatment of breast cancer more tolerable and successful. The end goal is to eradicate this disease. Continued support of innovative and high-impact research will someday hopefully lead to the cure.

October is Breast Cancer Awareness Month, and on Monday, Oct. 17, Gov. Tom Wolf held a ceremonial bill signing of legislation authored by Rep. Matt Baker (R-Tioga/Bradford/Potter), which requires insurance coverage of oral anti-cancer medication to be on the same level as intravenous treatments. House Bill 60, was officially signed into law in July.

No comments :